The main objective of this study was to assess whether cutaneous malignant melanoma (CMM) shows a stronger relation with the melanocytic nevi count at the site where CMM was diagnosed than with the melanocytic nevi count at other sites, stratifying by histologic CMM type, in a southern Mediterranean population. Cases and controls were selected from a population in southern Spain in 1988Spain in -1993. The study population included 116 incident cases with non-familial CMM (International Classification of Diseases 9th Revision (ICD-9) code 172), and 116 controls matched 1:1 for sex and age (±4 years). Data were collected by personal interview, and melanocytic nevi were counted over the entire body surface by clinical skin examination performed by a dermatologist. Crude and multiple risk factor-adjusted odds ratios and 95% confidence intervals were computed by conditional logistic regression analysis. After adjustment by skin type, unexposed skin color, and sun exposure, CMM was found to occur significantly more frequently in individuals with a high number of melanocytic nevi at the same site where CMM originated (odds ratio (OR) for >8 nevi = 12.0, 95% confidence interval (Cl) 1.3-108.2). The ability to predict the number of melanocytic nevi on different anatomic sites on CMM, but excluding the CMM cases on each corresponding site, was also examined. A significant trend with the number of nevi on the anterior surface of thighs was found (OR for >4 nevi = 4.5, 95% Cl 1.4-14.9). Melanocytic nevi count on the melanoma site was the variable most closely related to superficial spreading melanoma subtype (SSM) (OR for >8 nevi = 82.19, 95% Cl 2.72-2,454). On the other hand, the number of melanocytic nevi on the melanoma site was unrelated to risk of CMM subtypes other than SSM. These results support the hypothesis that nevi are an important risk factor for melanoma, especially SSM, in populations with a darker ethnic background. Am J Epidemiol 1997;145:1020-9.
other skin sites, it would strengthen the association between nevi and melanoma. Swerdlow et al. (4) divided skin surface into four wide areas (legs, trunk, head-neck, and arms), and they found that the number of nevi on these areas, apart from the legs, was not the best predictor for the development of CMM on the same anatomic area. Bain et al. (6) considered only two wide areas (upper limbs and lower limbs). They reported that the nevi counts on the lower limbs predicted better the risk of subsequent CMM on the same site. These studies suggest that the number of melanocytic nevi on the legs is the best predictor for CMM on the legs, but this relation does not hold for melanocytic nevi count on other anatomic areas (trunk, head-neck, or upper limbs) and CMM risk at corresponding areas. These findings do not support a causal relation between melanocytic nevi and CMM, despite the strong and consistent association that has been seen between them. Several reasons can be argued to explain the above-mentioned results: 1) there are several histologic types of CMM, and the association of Melanocytic Nevi and Risk of Cutaneous Malignant Melanoma 1021 melanocytic nevi with CMM changes according to histologic type (and histologic type is also associated with skin area); and 2) the areas defined by Swerdlow et al. (4) and Bain et al. (6) are rather wide and may not adequately reflect the number of nevi in the skin area where CMM is diagnosed.
Our main objective was to assess whether CMM risk shows a stronger relation with the melanocytic nevi count at the site where CMM was diagnosed than with the melanocytic nevi counts at other sites, stratifying by histologic CMM type. We carried out a case-control study in southern Spain, the lowest European latitude studied to date.
MATERIALS AND METHODS
The Dermatology Department of the University of Granada Hospital is the reference center for CMM in East Andalusia, which comprises the provinces of Granada, Almerfa, and Ja6n, has a population of 1,983,117, and is located at latitude 36° 45' north 38° 25' south.
The methods of this case-control study have been described elsewhere (20) . The present study included 11 additional cases to the ones included in Rodenas et al. (20) . A total of 116 patients with a histologically confirmed non-familial CMM (International Classification of Diseases 9th Revision (ICD-9) code 172) (21) , diagnosed in our hospital in 1988-1993, were included in the study. The diagnoses were: superficial spreading melanoma (SSM) in 65 cases (56.0 percent), nodular melanoma in 25 (21.6 percent), lentigo maligna melanoma in 19 (16.4 percent), and the acral lentiginous type in 7 (6.0 percent). The most frequent sites of CMM were lower extremities (35.3 percent), head and neck (22.4 percent), and back (25.9 percent). The mean depth was 2.41 mm (standard deviation 2.34, range 0.2-10.0 mm). Most patients were at clinical stage I (disease limited to the skin) at the time of the study (111 cases, 95.7 percent), while three cases (2.6 percent) were at stage II (lymph node metastases) and two cases (1.7 percent) were on stage III (distant metastases).
Initially, controls were planned to be obtained by random selection of municipal rolls. The lack of cooperation, mainly due to the required skin examination, forced us to use another source for the controls. Visitors to patients admitted in wards other than the dermatology ward, and who were without acute disease at the moment of the study, were solicited. Controls were selected from the visitors to the hospital on a random basis. People were asked to participate in an investigation on skin diseases; no specific mention was made of skin cancer or the study proposal. Of the 200 people who were invited to participate, 138 accepted (69 percent participation rate) and 116 were 1:1 matched for age (±4 years) and sex. The main reason for exclusion was refusal to take part in the skin examination.
Information was gathered by personal interview and clinical skin examination performed by a dermatologist. Cases and controls were interviewed by the same person who was not blind regarding case/control status. By means of a structured questionnaire with 203 items, data were collected on socio-economic factors (social class was classified in five levels according to the Black report, from I (highest) to V (lowest) (22) ), education, employment, alcohol intake, and tobacco consumption, past medical record including personal and family history of cutaneous disorders, gynecologic history, exposure to drugs, immunosupressive therapy, and ionizing radiation (in diagnostic or therapeutic procedures). Particular emphasis was paid to data on sunlight susceptibility and sun exposure. Individuals were asked about their skin response to an initial sun exposure (45 to 60 minutes of noontime exposure in the early summer), taking into account the reaction after 24 hours (propensity to bum) and after 7 days (ability to tan). Each subject was classified from I to VI according to the working classification of sunreactive skin types of Fitzpatrick (I, always burn, never tan; n, usually burn, tan less than average with difficulty; HI, sometimes mild burn, tan about average; IV, rarely burn, tan more than average with ease; V, never burn, always tan with brown skin; VI, never burn, black skin) (23) .
Individual sunlight exposure history was assessed in detail. We asked questions about place of birth and residences (altitude, rural or urban setting, and number of years at each place), number of hours spent daily, weekly, and monthly in occupational outdoor exposure in summer (April through September) and winter (October through March), recall with specific detail in every period of life (childhood, adolescence, and adulthood), and clothing habits and body surface area exposed (hat use, trunk, and extremities exposure). Sunlight exposure during recreational activities and vacations (intermittent sun exposure) also was examined with the same method for each period through life.
The entire cutaneous surface of participants was explored for pigmented lesions. Findings were noted down for every subject in a body surface map with 30 anatomic areas (24) . The site where CMM was diagnosed will be called the melanoma site. The nevi count on the melanoma site is based on the count on one of these 30 areas. The nevi count on the melanoma site was related to CMM risk. We also related the nevi counts on other sites to CMM risk. Initially, the analyses were done with the 30 sites; then, after we realized that the results did not change, the analyses were repeated reducing the number of skin sites from 30 to 14: face and neck, chest and abdomen, back, buttocks, medial surface of arms, lateral surface of arms, palms of hands, dorsum of hands, anterior surface of thighs, posterior surface of thighs, anterior surface of lower legs, posterior surface of lower legs, dorsum of feet, and soles of feet. These areas were defined taking clothing habits and amount of ultraviolet-exposure into account (14) .
Common acquired melanocytic nevi were counted and their diameter measured. Only nevi >2 mm were considered. Clinically atypical (dysplastic) melanocytic nevi were considered those with at least three of the following criteria: diameter ^5 mm, irregular borders, sharp margins, pebbled surface, not uniform color or irregular pigment distribution, and background erythema (25) . Melanocytic nevi were classified as congenital if their presence was determined accurately in the first year of life. Ephelides (freckles) on face, forearms, shoulders, and upper back, were assessed by comparison with an analogic scale from 0 (absence) to 100 (maximum intensity) (24) . The presence of other pigmented lesions and biologic markers of actinic damage (actinic keratosis or solar lentigo) also was noted. Color of sun-exposed skin (dorsum of hand) and of an unexposed site (upper inner arm) were evaluated on each patient from direct observation and classified as fair or dark. Eye color was recorded as black, brown, hazel, green, gray, or blue. Hair color was classified into four categories (black, brown, blond, or red); if color changed with age, hair color at ages 20-30 years was taken into account. Body weight and height also were measured. Clinical examinations were carried out in winter to minimize confounding factors such as evanescent freckles and summer tanning. Complete interview and skin examination lasted approximately 1-1.5 hours.
We related both number of melanocytic nevi on the melanoma site and on other non-melanoma sites to CMM risk. For the analyses with the nevi on each non-melanoma site, cases with CMM on the corresponding site were excluded; i.e., we tested the ability of nevi count on each anatomical site to predict CMM risk other than CMM developed on the same site. Odds ratio estimates for matched analysis and their 95 percent confidence intervals were calculated. Odds ratios were adjusted for potential confounders by conditional logistic regression; the variables included in the conditional logistic regression were unexposed skin color, skin type, total number of hours of recreational sun exposure, and total number of hours of occupational sun exposure. Confounders were identified using stratified analysis and logistic regression. We retained in the model those variables that changed the coefficient of the nevi count by more than 10 percent (26) . Explicit statistical tests for trend across exposure levels (number of nevi), controlling for all the confounding variables as for the adjusted odds ratio, were performed following the recommendations of Thompson (27) . All p values used to test for trend were two-tailed. Statistical analyses were performed using the BMDP statistical package (Dynamic version) (28) .
RESULTS
Several characteristics of the study population are detailed in table 1. We found no differences between cases and controls in regard to education, rent paid, marital status, life-style (alcohol drinking and smoking), sex, and age (mean ± standard error: cases, 50.4 ±1.3 years, and controls, 50.4 ± 1.4 years). % Total nevi minus nevi on the melanoma site.
The distribution of nevi by anatomic site and sex is displayed in table 2. The number of nevi (>2 mm of diameter) was higher in cases than in controls for both men and women. The sites with a higher number of nevi were arms, back, chest-abdomen (in men), and face-neck (in women).
A dose-response trend (p = 0.006) was observed after controlling for skin type, unexposed skin color, intermittent sun exposure, and occupational sun exposure between the number of all nevi (whole skin surface) and CMM risk (table 3) . The number of total nevi on the region in which CMM developed was also compared with that on the same site of the matching control (table 3) ; a statistically significant trend was observed (p = 0.049).
The relation between the non-melanoma anatomic site of melanocytic nevi counts and risk of CMM is also shown in table 3. The total number of nevi on non-melanoma sites (the difference between the number of nevi on the whole skin surface minus the number of nevi on melanoma site) showed a significant trend with CMM risk {p = 0.015). Apart from the anterior surface of thighs, no significant relation was found between the distinct non-melanoma sites and CMM risk. As previously noted, in the analysis of each non-melanoma site, the cases with CMM on each corresponding site were excluded.
The results were stratified by histologic type. In regard to SSM, we found clear and significant trends with total nevi, non-melanoma-site nevi, and melanoma-site nevi (table 4) . Nevi count on melanoma site yielded the highest odds ratio in its relation with SSM (odds ratio (OR) for >8 nevi = 82.2, 95 percent confidence interval (CI) 2.7-2,454). A significant odds ratio was also observed for nevi count on palms. Nevi counts on other sites were unrelated to SSM risk. In regard to nodular melanoma and lentigo maligna melanoma, no relation between melanoma site nevi count and CMM risk was seen (results not shown).
We did not find any atypical (dysplastic) nevus on the same site on which CMM was diagnosed. Back and chest-abdomen were the anatomic sites where we detected more atypical nevi. We could analyze the relation of CMM and atypical nevi on these two areas (table 5) . No significant association was observed with either all CMM nor SSM, although odds ratios for SSM were higher.
DISCUSSION
In this study, we found that, among different skin areas, the best predictor for CMM is melanocytic nevi count on the site where CMM appeared. This seems to be due to the relation between nevi and SSM because most CMM belong to this histologic type and the relation has not been observed with other histologic types. We have not found any report analyzing nevi count on the melanoma site and risk of SSM. Weinstock et al. (9) did not find a better relation between nevi count on the melanoma site and CMM than between the number of nevi at other sites and CMM; they reported that nevi count on the legs was Tabl» 3 continues the best predictor. Other reports agree with the abovementioned authors (4, 6, 13, 29) that nevi count on the legs is the best predictor, both in men and women where legs are the most frequent CMM localization.
Our results cannot be compared with those of these authors. We have tested the ability of nevi count on the legs to predict CMM risk but excluding CMMs on the legs; nevertheless, if all CMM cases were included in 
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Test for trend} Legs (anterior surface) (n -106 pairs) None
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Test for trend} Legs (posterior surface) (n -96 pairs) None
Test for trend} Dorsum of feet# (n -114 pairs) None * Adjusted by conditional logistic regression for unexposed skin color, skin type, total number of hours of recreational sun exposure, and total number of hours of occupational sun exposure.
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Soles of feet# (n ° 114 pairs) None
t The number of pairs next to site indicates the number of pairs counted For each non-melanoma site, cases with CMM developed on the corresponding site were excluded, e.g., there were 26 CMMs on the face and neck that were deleted in the analysis of that site, leaving 90 pairs.
} Two-sided p values for linear trend test by conditional logistic regression analysis controlling for all the confounding variables as for the adjusted odds ratio.
§ Number of melanocytic nevi on the site where CMM was diagnosed 11 Number of nevi on sites other than melanoma site. # Trend is not given because of the low number of subjects with 21 nevus.
the analysis, nevi count on the legs is the best predictor (results not shown). Several authors have analyzed CMM according to histologic type. Holly et al. (19) , in a recent study in San Francisco, analyzed the total number of large nevi and observed a strong relation between this variable and SSM; however, they did not analyze nevi count on the melanoma site. Elwood et al. (12) , in England, also reported an association between the number of nevi on the arms and SSM risk. Similar results were obtained in a French study (30) . These studies did not analyze nevi count on the melanoma site. Swerdlow et al. (4) analyzed their study population according to CMM histologic type. They found that nevi were more related to SSM and 
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Test for trend! Arms (medial surface) (n •> 64 pairs) None
1-5 >5
Test for trendy Arms (lateral surface) (n o 63 pairs) Table 4 continues nodular melanoma than to other histologic types. In an independent analysis, Swerdlow et al. (4) split their cases into four groups according to CMM site (legs, trunk, head and neck, and arms). They reported that nevi count on the legs was the best predictor for every site of CMM; so nevi count on the arms was not the best predictor for CMM at the arms, and the nevi counts on head-neck and on trunk were not the best predictors for CMM at headneck and trunk, respectively. They did not further stratify by histologic type; thus, it is unknown whether nevi * Adjusted by conditional logistic regression for unexposed skin color, skin type, total number of hours of recreational sun exposure, and total number of hours of occupational sun exposure.
t The number of pairs next to site indicates the number of pairs counted. For each non-melanoma site, cases with SSM developed on the corresponding site were excluded, e.g., there were 2 SSMs on the face and neck that were deleted in the analysis of that site, leaving 63 pairs.
* Two-sided p values for linear trend test by conditional logistic regression analysis controlling for all the confounding variables as for the adjusted odds ratio.
§ Number of melanocytic nevi on the site where SSM was diagnosed. D Number of nevi on sites other than melanoma site. * Trend is not given because of the low number of subjects with 2:1 nevus.
count on the melanoma site was the best predictor for SSM in their series.
The trend that we observed with total number of melanocytic nevi agrees with the results of other reports (4, 6, 19, 20, 30) . The relation between the total number of nevi on non-melanoma sites (total number of nevi minus melanoma-site nevi) and CMM risk cannot be compared because we could not identify any previous study that analyzed this relation. In people with CMM, non-melanoma sites can show, although to a lesser degree than melanoma sites, a higher number of nevi than controls (after adjustment for sun exposure). All anatomic skin sites may share a similar genetic background and thus can justify the trend 
Superficial spreading melanoma
Chest and abdomen None * Adjusted by conditional log'stic regression for unexposed skin color, skin type, total number of hours of recreational sun exposure, and total number of hours of occupational sun exposure.
observed between total non-melanoma-site nevi and CMM risk.
The stronger relation between nevi on the melanoma site and SSM is in a direction compatible with the hypothesis that melanocytic nevi are precursors of SSM (31) . This is also supported by ultrastructural evidence (32) . Remnants of normal nevi, and melanocytic dysplasia associated with sun damage, have been found in excision biopsies of SSM (33) . At present, atypical (dysplastic) melanocytic nevi are considered to be an intermediate step in the chain of events which leads from sun exposure to CMM (34, 35) . We did not find any atypical nevi on melanoma site. This may reflect either that dysplastic nevi progress to CMM according to the above-mentioned theory (34, 35) or, on the contrary, that dysplastic nevi play a less important role in our population (southern European) than in other communities (Anglo-Saxon or north European). Previous studies (5, 20, 36) support the latter opinion. Nevertheless, it should be emphasized that the number of atypical nevi is too small to allow appropriate statistical analysis.
There are several potential limitations to our study. One is selection bias: controls were chosen among visitors to the hospital. No major differences were found between cases and controls according to social class, income, years of education, and life-style. Furthermore, the classic risk factors for CMM (total number of nevi, sunbathing, sunburns, intermittent sun exposure, and occupational sun exposure) were identified in this study and have been reported elsewhere (20) . The absence of major differences between cases and controls in regard to life-style and social class, and the identification of the well-known risk factors of CMM in our study population do not support the existence of selection bias. Nevertheless, because our study design is a hospital-based case-control study, this design may be a potential limitation for inference.
The higher number of women in our CMM series reflects the epidemiology of melanoma in Spain. According to the data of seven Spanish population-based cancer registries, the incidence rate of CMM is 35-80 percent higher in women than in men (37). In addition, in the age groups (>50 years) where CMM is more frequently diagnosed (53.4 percent of our case series), there is a 45:55 men:women ratio in our target population. These facts justify the 1:2 men:women ratio found in our case series.
Another major drawback of the present report is sample size; it is small, especially if it is compared with other studies (10, 18) , and it may imply lack of statistical power to detect some associations. Nevertheless, given the high magnitude of some of the observed odds ratios, we believe it may be adequate for CMM and SSM, although not for other hystologic types of CMM and for the analysis of atypical nevi. Our sample size does not allow stratification by anatomic site to assess whether site-specific nevi counts predict site-specific CMM.
In conclusion, our results suggest that the number of melanocytic nevi at a specific anatomic area has an important influence in the risk of CMM at the same zone, especially for the SSM type, where melanocytic nevi count on the melanoma site is the best predictor. These results may be applied to CMM screening, because they imply that skin sites with a high number of nevi should be monitored carefully.
